• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News > Message on the passing of Dr Alwyn Mwinga from DNDi Executive Director Dr Luis Pizarro > Page 12

Message on the passing of Dr Alwyn Mwinga from DNDi Executive Director Dr Luis Pizarro

6 Sep 2024

A message from DNDi Executive Director Dr Luis Pizarro:

We are deeply saddened by news of the death of DNDi Board Member Dr Alwyn Mwinga.

Dr Mwinga first joined DNDi’s Board in 2015, and over the last nine years served as the patient representative. It was a privilege to work alongside Dr Mwinga, and see first-hand how she brought her life-long dedication to patient rights and well-being to passionately support DNDi’s mission that no patient should be left behind.

Dr Mwinga will be remembered fondly for giving a much-needed voice to patients whose needs would otherwise have been neglected. On behalf of the whole DNDi team, I send my sincere condolences to her friends, family, and everyone who knew and worked with her.

Alwyn Mwinga

Dr Alwyn Gladwyn Zebron Mwinga was the Chief Executive Officer of the Zambia AIDS Related Tuberculosis Project (Zambart). Before joining Zambart, she worked in different capacities at CDC Zambia. She was an Expert Consultant on TB/HIV Research Priorities for the WHO in addition to serving as a member of multiple national and international boards relating to TB. She was an Associate Editor of The Lancet Infectious Diseases and the International Journal of Tuberculosis and Lung Diseases and a Senior Lecturer at the University of Zambia.

In 2007, Dr Mwinga was awarded the Global Health Achievement by the Office of Global Health CDC as well as the PEPFAR Lifetime Achievement Award in 2011 in recognition of her contribution to HIV and TB.

She studied Tropical Medicine (M.Sc.) at the University of London, and she had a M.Med and MB ChB from the University of Zambia. In 2013 she completed her PG Diploma in Bioethics at the University of Stellenbosch.

Read, watch, share

Loading...
Vials in a lab for testing
Press releases
10 Jan 2024

Clinical trial confirms the tolerability of the drug fexinidazole in the treatment of Chagas disease

BioSpectrum Asia logo
Viewpoints
31 Dec 2023

Biomedical innovation: Answer for climate-sensitive diseases

BioSpectrum Asia
Hand holding a pill
Press releases
15 Dec 2023

EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa

Lab activities
Press releases
8 Dec 2023

Nagasaki University, DNDi, and GHIT Fund sign agreement to collaborate on drug screening for Chagas disease

Doctor with patient in hospital setting
Press releases
5 Dec 2023

Cryptococcal meningitis: new report highlights slow uptake of guidelines shown to reduce deaths in Africa

Healthcare worker with patient
Press releases
3 Dec 2023

Germany’s Federal Ministry for Economic Cooperation and Development (BMZ) through KfW grants funding to fast-track access to medicines for poverty-related and neglected diseases

Laboratory staff working
News
3 Dec 2023

DNDi commits to cutting carbon emissions in half by 2030

Cover image for the film 'Mycetoma: Neglected but not Forgotten'
Videos
23 Nov 2023

Mycetoma: Neglected but not Forgotten

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License